The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...
The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Novo Nordisk ( NYSE:NVO) and Eli Lilly ( NYSE:LLY) are making headlines againthis time, for potential benefits beyond weight ...
From Alzheimer's prevention to weight-loss dominance, Novo bets on innovation and share repurchases amid Medicare pressure.
When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...
If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...